Skip to main content
Borosil Scientific Limited logo

Borosil Scientific Limited — Investor Relations & Filings

Ticker · BOROSCI ISIN · INE02L001032 LEI · 9845000KHFF9A4F3BF28 BSE.NS Manufacturing
Open in API
Filings indexed 124 across all filing types
Latest filing 2026-05-27 Investor Presentation
Country IN India
Listing BSE.NS BOROSCI

About Borosil Scientific Limited

https://www.borosilscientific.com

Borosil Scientific Limited specializes in the manufacture and distribution of high-quality laboratory glassware and scientific instruments. The company provides a comprehensive range of products, including beakers, flasks, cylinders, pipettes, and specialized laboratory apparatus designed for precision and durability. Its offerings cater to diverse sectors such as pharmaceuticals, biotechnology, research and development, and educational institutions. Utilizing advanced borosilicate glass technology, the company ensures its products exhibit superior thermal shock resistance and chemical durability. In addition to glassware, the portfolio includes laboratory equipment and primary packaging solutions for the healthcare industry. Borosil Scientific Limited is recognized for its commitment to accuracy and international quality standards, supporting critical scientific processes and industrial applications.

Recent filings

Filing Released Lang Actions
Investor Presentation on financial results for the quarter and financial year ended March 31, 2026
Investor Presentation Classification · 95% confidence The document is titled “Investor Presentation Q4FY26” and contains slide-based presentation content including company overview, business segments, financial overviews, and strategic highlights. It is provided pursuant to SEBI LODR Regulation 30 as a presentation to investors rather than a full regulatory report (e.g., 10-K or Quarterly Report). This matches the definition of an Investor Presentation (IP).
2026-05-27 English
Updates
Investor Presentation Classification · 92% confidence The document is a detailed slide deck titled “Investor Presentation Q4FY26” containing financial highlights, segment overviews, strategic narrative, and forward-looking statements. It was filed under SEBI LODR Regulation 30 as an investor presentation on audited results, not merely an announcement or proxy statement. It contains substantive presentation content (financial tables, strategy slides) rather than just linking to a report. Therefore, it should be classified as an Investor Presentation.
2026-05-27 English
Annual Secretarial Compliance Report for the Financial Year 2025-26
Regulatory Filings Classification · 85% confidence The document is titled “Annual Secretarial Compliance Report” filed under Regulation 24A of SEBI LODR Regulations. It is a compliance certificate/attestation by the Company Secretary and does not constitute a financial report (e.g., Annual Report, Interim Report) nor a corporate governance charter, but rather a regulatory compliance filing. Per the CERTIFICATION RULE, officer certifications and compliance attestations are classified as Regulatory Filings (RNS).
2026-05-22 English
Options to purchase securities
Share Issue/Capital Change Classification · 90% confidence The document is a formal intimation to stock exchanges under SEBI LODR regulations announcing the grant of 18,700 employee stock options under the company’s ESOP scheme. It is not a management discussion, earnings release, or AGM material, nor is it a director’s personal trade. It deals with the allotment/issuance of equity-linked instruments (options) that will eventually change the company’s capital base upon exercise. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-05-20 English
Grant of Stock Options under Borosil Scientific Limited- Employee Stock Option Scheme
Share Issue/Capital Change Classification · 82% confidence The document is an official stock exchange filing under SEBI LODR Regulations notifying the grant of 18,700 employee stock options under the company’s ESOP scheme. It details grant terms, vesting schedule, pricing and share impact. This is a corporate action announcing a future share issuance under an employee option plan, which constitutes a change in share capital. Therefore, it should be classified as a Share Issue/Capital Change (SHA).
2026-05-20 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-20 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.